DE60126645D1 - Sulfonamidether - substituierte imidazochinoline - Google Patents

Sulfonamidether - substituierte imidazochinoline

Info

Publication number: DE60126645D1
Authority: DE; Germany
Prior art keywords: sulfonamidether; imidazochinoline; substituted; substituted imidazochinoline
Prior art date: 2000-12-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE60126645T

Other languages

English (en)

Other versions

DE60126645T2 (de

Inventor

L Crooks

W Greisgraber

D Heppner

A Merrill

R Roberts

Ai-Ping Woodburry Wei

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

3M Innovative Properties Co

Original Assignee

3M Innovative Properties Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-08

Filing date

2001-12-06

Publication date

2007-03-29

2001-12-06 Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co

2007-03-29 Publication of DE60126645D1 publication Critical patent/DE60126645D1/de

2007-11-22 Application granted granted Critical

2007-11-22 Publication of DE60126645T2 publication Critical patent/DE60126645T2/de

2021-12-07 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

DE60126645T 2000-12-08 2001-12-06 Sulfonamidether - substituierte imidazochinoline Expired - Fee Related DE60126645T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US25421800P	2000-12-08	2000-12-08
US254218P		2000-12-08
PCT/US2001/046582 WO2002046190A2 (en)	2000-12-08	2001-12-06	Sulfonamido ether substituted imidazoquinolines

Publications (2)

Publication Number	Publication Date
DE60126645D1 true DE60126645D1 (de)	2007-03-29
DE60126645T2 DE60126645T2 (de)	2007-11-22

Family

ID=22963391

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DE60111076T Expired - Lifetime DE60111076T2 (de)	2000-12-08	2001-12-06	Thioethersubstituierte imidazochinoline
DE60117859T Expired - Fee Related DE60117859T2 (de)	2000-12-08	2001-12-06	HARNSTOFFSUBSTITUIERTE IMIDAZOCHINOLINETHER und Arzneimittel, die diese umfassen.
DE60126645T Expired - Fee Related DE60126645T2 (de)	2000-12-08	2001-12-06	Sulfonamidether - substituierte imidazochinoline

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
DE60111076T Expired - Lifetime DE60111076T2 (de)	2000-12-08	2001-12-06	Thioethersubstituierte imidazochinoline
DE60117859T Expired - Fee Related DE60117859T2 (de)	2000-12-08	2001-12-06	HARNSTOFFSUBSTITUIERTE IMIDAZOCHINOLINETHER und Arzneimittel, die diese umfassen.

Country Status (32)

Country	Link
US (8)	US6670372B2 (de)
EP (6)	EP1341790B1 (de)
JP (7)	JP2004515501A (de)
KR (6)	KR20030070050A (de)
CN (6)	CN1252070C (de)
AR (6)	AR035664A1 (de)
AT (3)	ATE296301T1 (de)
AU (12)	AU2002230618B2 (de)
BR (6)	BR0116047A (de)
CA (6)	CA2431151A1 (de)
CY (2)	CY1105586T1 (de)
CZ (6)	CZ20031561A3 (de)
DE (3)	DE60111076T2 (de)
DK (3)	DK1343784T3 (de)
EE (6)	EE200300272A (de)
ES (3)	ES2281456T3 (de)
HK (3)	HK1064383A1 (de)
HR (6)	HRP20030462A2 (de)
HU (6)	HUP0400704A2 (de)
IL (6)	IL156044A0 (de)
MX (6)	MXPA03004975A (de)
NO (6)	NO20032449D0 (de)
NZ (6)	NZ526106A (de)
PL (7)	PL365883A1 (de)
PT (2)	PT1341790E (de)
RU (6)	RU2003116063A (de)
SI (1)	SI1341790T1 (de)
SK (6)	SK7152003A3 (de)
TW (3)	TWI293300B (de)
UA (2)	UA75622C2 (de)
WO (6)	WO2002046188A2 (de)
ZA (6)	ZA200305273B (de)

Families Citing this family (206)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5741908A (en)	1996-06-21	1998-04-21	Minnesota Mining And Manufacturing Company	Process for reparing imidazoquinolinamines
UA67760C2 (uk) *	1997-12-11	2004-07-15	Міннесота Майнінг Енд Мануфакчурінг Компані	Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
US6573273B1 (en) *	1999-06-10	2003-06-03	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6541485B1 (en)	1999-06-10	2003-04-01	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6756382B2 (en)	1999-06-10	2004-06-29	3M Innovative Properties Company	Amide substituted imidazoquinolines
US6331539B1 (en)	1999-06-10	2001-12-18	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
US6916925B1 (en)	1999-11-05	2005-07-12	3M Innovative Properties Co.	Dye labeled imidazoquinoline compounds
JP3436512B2 (ja) *	1999-12-28	2003-08-11	株式会社デンソー	アクセル装置
US6664265B2 (en)	2000-12-08	2003-12-16	3M Innovative Properties Company	Amido ether substituted imidazoquinolines
US6677347B2 (en) *	2000-12-08	2004-01-13	3M Innovative Properties Company	Sulfonamido ether substituted imidazoquinolines
US6660747B2 (en) *	2000-12-08	2003-12-09	3M Innovative Properties Company	Amido ether substituted imidazoquinolines
US6545016B1 (en)	2000-12-08	2003-04-08	3M Innovative Properties Company	Amide substituted imidazopyridines
UA75622C2 (en) *	2000-12-08	2006-05-15	3M Innovative Properties Co	Aryl ether substituted imidazoquinolines, pharmaceutical composition based thereon
US6664264B2 (en) *	2000-12-08	2003-12-16	3M Innovative Properties Company	Thioether substituted imidazoquinolines
US6677348B2 (en)	2000-12-08	2004-01-13	3M Innovative Properties Company	Aryl ether substituted imidazoquinolines
US6667312B2 (en)	2000-12-08	2003-12-23	3M Innovative Properties Company	Thioether substituted imidazoquinolines
US6660735B2 (en) *	2000-12-08	2003-12-09	3M Innovative Properties Company	Urea substituted imidazoquinoline ethers
US6545017B1 (en)	2000-12-08	2003-04-08	3M Innovative Properties Company	Urea substituted imidazopyridines
US6525064B1 (en)	2000-12-08	2003-02-25	3M Innovative Properties Company	Sulfonamido substituted imidazopyridines
US7226928B2 (en) *	2001-06-15	2007-06-05	3M Innovative Properties Company	Methods for the treatment of periodontal disease
ES2312659T3 (es) *	2001-11-29	2009-03-01	3M Innovative Properties Company	Formulaciones farmaceuticas que comprenden un modificador de la respuesta inmune.
CA2365732A1 (en)	2001-12-20	2003-06-20	Ibm Canada Limited-Ibm Canada Limitee	Testing measurements
US6677349B1 (en)	2001-12-21	2004-01-13	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
IL147953A (en) *	2002-02-01	2008-04-13	Meir Bialer	Derivatives and pharmaceutical compositions of n-hydroxymethyl tetramethylcyclopropyl-
JP2005518433A (ja) *	2002-02-22	2005-06-23	スリーエムイノベイティブプロパティズカンパニー	Ｕｖｂ−誘導免疫抑制を軽減し治療する方法
GB0211649D0 (en)	2002-05-21	2002-07-03	Novartis Ag	Organic compounds
JP2005538057A (ja)	2002-06-07	2005-12-15	スリーエムイノベイティブプロパティズカンパニー	エーテル置換イミダゾピリジン
CA2491680C (en) *	2002-07-02	2012-04-17	Southern Research Institute	Inhibitors of ftsz and uses thereof
AU2003299863B2 (en) *	2002-08-15	2009-09-24	3M Innovative Properties Company	Immunostimulatory compositions and methods of stimulating an immune response
AU2003299082A1 (en)	2002-09-26	2004-04-19	3M Innovative Properties Company	1h-imidazo dimers
AU2003301052A1 (en)	2002-12-20	2004-07-22	3M Innovative Properties Company	Aryl / hetaryl substituted imidazoquinolines
US7387271B2 (en)	2002-12-30	2008-06-17	3M Innovative Properties Company	Immunostimulatory combinations
WO2004071459A2 (en)	2003-02-13	2004-08-26	3M Innovative Properties Company	Methods and compositions related to irm compounds and toll-like receptor 8
US7485432B2 (en)	2003-02-27	2009-02-03	3M Innovative Properties Company	Selective modulation of TLR-mediated biological activity
AU2004218349A1 (en)	2003-03-04	2004-09-16	3M Innovative Properties Company	Prophylactic treatment of UV-induced epidermal neoplasia
US7163947B2 (en) *	2003-03-07	2007-01-16	3M Innovative Properties Company	1-Amino 1H-imidazoquinolines
CA2517655A1 (en) *	2003-03-07	2004-09-23	3M Innovative Properties Company	1-amino 1h-imidazoquinolines
WO2004080293A2 (en) *	2003-03-13	2004-09-23	3M Innovative Properties Company	Methods for diagnosing skin lesions
CA2518445A1 (en)	2003-03-13	2004-09-23	3M Innovative Properties Company	Method of tattoo removal
MXPA05009694A (es) *	2003-03-13	2005-10-20	3M Innovative Properties Co	Metodos para mejorar la calidad de la piel.
US20040192585A1 (en) *	2003-03-25	2004-09-30	3M Innovative Properties Company	Treatment for basal cell carcinoma
US20040265351A1 (en) *	2003-04-10	2004-12-30	Miller Richard L.	Methods and compositions for enhancing immune response
AU2004244962A1 (en)	2003-04-10	2004-12-16	3M Innovative Properties Company	Delivery of immune response modifier compounds using metal-containing particulate support materials
EP1617845A4 (de) *	2003-04-28	2006-09-20	3M Innovative Properties Co	Zusammensetzungen und verfahren zur induktion von opioid-rezeptoren
WO2004110992A2 (en) *	2003-06-06	2004-12-23	3M Innovative Properties Company	Process for imidazo[4,5-c] pyridin-4-amines
WO2004110991A2 (en) *	2003-06-06	2004-12-23	3M Innovative Properties Company	PROCESS FOR IMIDAZO[4,5-c]PYRIDIN-4-AMINES
WO2005016273A2 (en) *	2003-08-05	2005-02-24	3M Innovative Properties Company	Infection prophylaxis using immune response modifier compounds
JP2007502288A (ja) *	2003-08-12	2007-02-08	スリーエムイノベイティブプロパティズカンパニー	オキシム置換イミダゾ含有化合物
JP4913593B2 (ja) *	2003-08-14	2012-04-11	スリーエムイノベイティブプロパティズカンパニー	脂質修飾された免疫応答調整剤
PL1653959T3 (pl) *	2003-08-14	2015-10-30	3M Innovative Properties Co	Modyfikatory odpowiedzi immunologicznej modyfikowane lipidami
EP1660122A4 (de) *	2003-08-25	2007-10-24	3M Innovative Properties Co	Immunstimulatorische kombinationen und behandlungen
AU2004268616B2 (en) *	2003-08-25	2010-10-07	3M Innovative Properties Company	Delivery of immune response modifier compounds
EP1658076B1 (de)	2003-08-27	2013-03-06	3M Innovative Properties Company	Aryloxy- und arylalkylenoxy-substituierte imidazochinoline
JP2007504172A (ja) *	2003-09-02	2007-03-01	スリーエムイノベイティブプロパティズカンパニー	粘膜に関連した症状の処置に関する方法
AU2004270201A1 (en) *	2003-09-05	2005-03-17	3M Innovative Properties Company	Treatment for CD5+ B cell lymphoma
EP1664342A4 (de) *	2003-09-17	2007-12-26	3M Innovative Properties Co	Selektive modulation der expression des tlr-gens
US7544697B2 (en)	2003-10-03	2009-06-09	Coley Pharmaceutical Group, Inc.	Pyrazolopyridines and analogs thereof
US20090075980A1 (en) *	2003-10-03	2009-03-19	Coley Pharmaceutical Group, Inc.	Pyrazolopyridines and Analogs Thereof
AU2004315876B2 (en)	2003-10-03	2011-05-26	3M Innovative Properties Company	Pyrazolopyridines and analogs thereof
BRPI0414856A (pt) *	2003-10-03	2006-11-21	3M Innovative Properties Co	imidazoquinolinas alcóxi-substituìdas
WO2005041891A2 (en) *	2003-10-31	2005-05-12	3M Innovative Properties Company	Neutrophil activation by immune response modifier compounds
CA2545774A1 (en)	2003-11-14	2005-06-02	3M Innovative Properties Company	Oxime substituted imidazo ring compounds
WO2005048945A2 (en) *	2003-11-14	2005-06-02	3M Innovative Properties Company	Hydroxylamine substituted imidazo ring compounds
CN1902200A (zh) *	2003-11-21	2007-01-24	诺瓦提斯公司	用做蛋白激酶抑制剂的1h－咪唑并喹啉类衍生物
AR046845A1 (es) *	2003-11-21	2005-12-28	Novartis Ag	Derivados de 1h-imidazo[4,5-c]quinolina para tratamiento de enfermedades dependientes de las proteino-quinasas
US8778963B2 (en) *	2003-11-25	2014-07-15	3M Innovative Properties Company	Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
US8691837B2 (en)	2003-11-25	2014-04-08	3M Innovative Properties Company	Substituted imidazo ring systems and methods
US8940755B2 (en) *	2003-12-02	2015-01-27	3M Innovative Properties Company	Therapeutic combinations and methods including IRM compounds
AU2004315771A1 (en) *	2003-12-04	2005-08-25	3M Innovative Properties Company	Sulfone substituted imidazo ring ethers
WO2005066170A1 (en)	2003-12-29	2005-07-21	3M Innovative Properties Company	Arylalkenyl and arylalkynyl substituted imidazoquinolines
WO2005066172A1 (en) *	2003-12-29	2005-07-21	3M Innovative Properties Company	Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds
EP1699398A4 (de) *	2003-12-30	2007-10-17	3M Innovative Properties Co	Verbesserung der immunantworten
US8735421B2 (en)	2003-12-30	2014-05-27	3M Innovative Properties Company	Imidazoquinolinyl sulfonamides
WO2005065678A1 (en) *	2003-12-30	2005-07-21	3M Innovative Properties Company	Immunomodulatory combinations
CA2559607C (en) *	2004-03-15	2013-02-19	3M Innovative Properties Company	Immune response modifier formulations and methods
WO2005094531A2 (en)	2004-03-24	2005-10-13	3M Innovative Properties Company	Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
AU2005244260B2 (en) *	2004-04-09	2010-08-05	3M Innovative Properties Company	Methods, compositions, and preparations for delivery of immune response modifiers
US20050267145A1 (en) *	2004-05-28	2005-12-01	Merrill Bryon A	Treatment for lung cancer
US20080015184A1 (en) *	2004-06-14	2008-01-17	3M Innovative Properties Company	Urea Substituted Imidazopyridines, Imidazoquinolines, and Imidazonaphthyridines
WO2005123080A2 (en)	2004-06-15	2005-12-29	3M Innovative Properties Company	Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
EP1765348B1 (de) *	2004-06-18	2016-08-03	3M Innovative Properties Company	Substituierte imidazochinoline, imidazopyridine sowie imidazonaphthyridine
US20070259881A1 (en) *	2004-06-18	2007-11-08	Dellaria Joseph F Jr	Substituted Imidazo Ring Systems and Methods
WO2006009826A1 (en)	2004-06-18	2006-01-26	3M Innovative Properties Company	Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006038923A2 (en)	2004-06-18	2006-04-13	3M Innovative Properties Company	Aryl substituted imidazonaphthyridines
WO2006065280A2 (en)	2004-06-18	2006-06-22	3M Innovative Properties Company	Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
US8541438B2 (en)	2004-06-18	2013-09-24	3M Innovative Properties Company	Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
CA2578975A1 (en)	2004-09-02	2006-03-16	3M Innovative Properties Company	2-amino 1h imidazo ring systems and methods
US20090270443A1 (en) *	2004-09-02	2009-10-29	Doris Stoermer	1-amino imidazo-containing compounds and methods
CA2578741C (en) *	2004-09-02	2014-01-14	3M Innovative Properties Company	1-alkoxy 1h-imidazo ring systems and methods
WO2006029223A2 (en) *	2004-09-08	2006-03-16	Children's Medical Center Corporation	Method for stimulating the immune response of newborns
RU2415857C2 (ru) *	2004-09-14	2011-04-10	Новартис Вэксинс Энд Диагностикс Инк.	Имидазохинолиновые соединения
WO2006042254A2 (en) *	2004-10-08	2006-04-20	3M Innovative Properties Company	Adjuvant for dna vaccines
WO2006063072A2 (en) *	2004-12-08	2006-06-15	3M Innovative Properties Company	Immunomodulatory compositions, combinations and methods
US8080560B2 (en)	2004-12-17	2011-12-20	3M Innovative Properties Company	Immune response modifier formulations containing oleic acid and methods
WO2006074003A2 (en) *	2004-12-30	2006-07-13	3M Innovative Properties Company	CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS
CA2594674C (en)	2004-12-30	2016-05-17	3M Innovative Properties Company	Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
ES2538498T3 (es)	2004-12-30	2015-06-22	Meda Ab	Utilización de Imiquimod para el tratamiento de metástasis cutáneas provenientes de un tumor de cáncer de mama
CA2592897A1 (en) *	2004-12-30	2006-07-13	Takeda Pharmaceutical Company Limited	1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine methanesulfonate
US8436176B2 (en) *	2004-12-30	2013-05-07	Medicis Pharmaceutical Corporation	Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
US9248127B2 (en)	2005-02-04	2016-02-02	3M Innovative Properties Company	Aqueous gel formulations containing immune response modifiers
CA2602083A1 (en)	2005-02-09	2006-08-09	Coley Pharmaceutical Group, Inc.	Oxime and hydroxylamine substituted thiazolo(4,5-c) ring compounds and methods
AU2006212765B2 (en) *	2005-02-09	2012-02-02	3M Innovative Properties Company	Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines
US7968563B2 (en)	2005-02-11	2011-06-28	3M Innovative Properties Company	Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
US8658666B2 (en)	2005-02-11	2014-02-25	3M Innovative Properties Company	Substituted imidazoquinolines and imidazonaphthyridines
WO2006089264A2 (en)	2005-02-18	2006-08-24	Novartis Vaccines And Diagnostics Inc.	Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
JP2008530245A (ja)	2005-02-18	2008-08-07	ノバルティスヴァクシンズアンドダイアグノスティクス，インコーポレイテッド	尿路病原性菌株由来の抗原
US8158794B2 (en)	2005-02-23	2012-04-17	3M Innovative Properties Company	Hydroxyalkyl substituted imidazoquinoline compounds and methods
CA2598695A1 (en)	2005-02-23	2006-09-21	Coley Pharmaceutical Group, Inc.	Hydroxyalkyl substituted imidazoquinolines
EP1850849A2 (de)	2005-02-23	2007-11-07	Coley Pharmaceutical Group, Inc.	Verfahren zur vorzugsweisen herbeiführung der biosynthese von interferon
CA2598639A1 (en)	2005-02-23	2006-08-31	Coley Pharmaceutical Group, Inc.	Hydroxyalkyl substituted imidazonaphthyridines
AU2006223148A1 (en)	2005-03-14	2006-09-21	3M Innovative Properties Company	Method of treating actinic keratosis
AU2006232375A1 (en)	2005-04-01	2006-10-12	Coley Pharmaceutical Group, Inc.	1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
EP1869043A2 (de)	2005-04-01	2007-12-26	Coley Pharmaceutical Group, Inc.	Pyrazolopyridin-1,4-diamine und analoge davon
JP2008539252A (ja) *	2005-04-25	2008-11-13	スリーエムイノベイティブプロパティズカンパニー	免疫活性化組成物
CA2615626A1 (en)	2005-07-18	2007-01-25	Novartis Ag	Small animal model for hcv replication
US8476292B2 (en)	2005-09-09	2013-07-02	3M Innovative Properties Company	Amide and carbamate derivatives of N-{2-[4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c] quinolin-1-Yl]-1,1-dimethylethyl}methanesulfonamide and methods
ZA200803029B (en) *	2005-09-09	2009-02-25	Coley Pharm Group Inc	Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
US8889154B2 (en)	2005-09-15	2014-11-18	Medicis Pharmaceutical Corporation	Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation
CA2628328A1 (en)	2005-11-04	2007-05-10	Novartis Vaccines And Diagnostics S.R.L.	Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
US20090304742A1 (en)	2005-11-04	2009-12-10	Novartis Vaccines And Diagnostics Srl	Influenza vaccines with reduced amount of emulsion adjuvant
CA2628424A1 (en)	2005-11-04	2007-05-10	Novartis Vaccines And Diagnostics S.R.L.	Adjuvanted influenza vaccines including cytokine-inducing agents
EP1948173B1 (de)	2005-11-04	2013-07-17	3M Innovative Properties Company	Hydroxy- und alkoxy-substituierte 1h-imidazochinoline und verfahren
HUE051122T2 (hu)	2005-11-04	2021-03-01	Seqirus Uk Ltd	Sejttenyészetben növesztett influenzavírusból elõállított nemvirion anti-géneket tartalmazó adjuvált vakcinák
PT2478916T (pt)	2006-01-27	2020-07-03	Seqirus Uk Ltd	Vacinas de influenza que contêm hemaglutinina e proteínas da matriz
EP3085373A1 (de)	2006-02-22	2016-10-26	3M Innovative Properties Company	Konjugate zur modifizierung von immunreaktionen
WO2007106854A2 (en)	2006-03-15	2007-09-20	Coley Pharmaceutical Group, Inc.	Hydroxy and alkoxy substituted 1h-imidazonaphthyridines and methods
WO2007109813A1 (en)	2006-03-23	2007-09-27	Novartis Ag	Imidazoquinoxaline compounds as immunomodulators
EP2010530A2 (de) *	2006-03-23	2009-01-07	Novartis AG	Herstellungsverfahren für imidazolhaltige verbindungen
CA2646891A1 (en) *	2006-03-23	2007-09-27	Novartis Ag	Immunopotentiating compounds
EP2382987A1 (de)	2006-03-24	2011-11-02	Novartis Vaccines and Diagnostics GmbH	Lagerung von Influenza-Impfstoffen ohne Kühlung
CA2647942A1 (en)	2006-03-31	2007-11-08	Novartis Ag	Combined mucosal and parenteral immunization against hiv
US20100015168A1 (en)	2006-06-09	2010-01-21	Novartis Ag	Immunogenic compositions for streptococcus agalactiae
US7906506B2 (en) *	2006-07-12	2011-03-15	3M Innovative Properties Company	Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
GB0614460D0 (en)	2006-07-20	2006-08-30	Novartis Ag	Vaccines
US20100166788A1 (en)	2006-08-16	2010-07-01	Novartis Vaccines And Diagnostics	Immunogens from uropathogenic escherichia coli
US8178539B2 (en)	2006-09-06	2012-05-15	3M Innovative Properties Company	Substituted 3,4,6,7-tetrahydro-5H-1,2a,4a,8-tetraazacyclopenta[cd]phenalenes and methods
ES2536401T3 (es)	2006-09-11	2015-05-25	Novartis Ag	Fabricación de vacunas contra virus de la gripe sin usar huevos
US20110045022A1 (en)	2006-12-06	2011-02-24	Theodore Tsai	Vaccines including antigen from four strains of influenza virus
US20080149123A1 (en)	2006-12-22	2008-06-26	Mckay William D	Particulate material dispensing hairbrush with combination bristles
GB0700562D0 (en)	2007-01-11	2007-02-21	Novartis Vaccines & Diagnostic	Modified Saccharides
PT2185191E (pt)	2007-06-27	2012-11-27	Novartis Ag	Vacinas contra a gripe com baixo teor de aditivos
GB0714963D0 (en)	2007-08-01	2007-09-12	Novartis Ag	Compositions comprising antigens
GB0810305D0 (en)	2008-06-05	2008-07-09	Novartis Ag	Influenza vaccination
GB0818453D0 (en)	2008-10-08	2008-11-12	Novartis Ag	Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
UA101339C2 (ru) *	2008-01-15	2013-03-25	Меда Аб	Лечение заболеваний толстой кишки или предотвращение карциномы толстого кишечника с помощью имидазохинолиновых производных
WO2009111337A1 (en)	2008-03-03	2009-09-11	Irm Llc	Compounds and compositions as tlr activity modulators
EP2268309B1 (de)	2008-03-18	2015-01-21	Novartis AG	Verbesserungen der herstellung von grippevirus-impstoff-antigenen
AU2010220103A1 (en)	2009-03-06	2011-09-22	Novartis Ag	Chlamydia antigens
AU2010229835B2 (en)	2009-03-25	2015-01-15	The Board Of Regents Of The University Of Texas System	Compositions for stimulation of mammalian innate immune resistance to pathogens
SG175092A1 (en)	2009-04-14	2011-11-28	Novartis Ag	Compositions for immunising against staphylococcus aerus
USH2283H1 (en)	2009-04-27	2013-09-03	Novartis Ag	Vaccines for protecting against influenza
GB0907551D0 (en) *	2009-05-01	2009-06-10	Univ Dundee	Treatment or prophylaxis of proliferative conditions
AU2013203591B2 (en) *	2009-05-01	2017-01-19	University Court Of The University Of Dundee	Treatment or prophylaxis of proliferative conditions
SG178026A1 (en)	2009-07-15	2012-03-29	Novartis Ag	Rsv f protein compositions and methods for making same
ES2526996T3 (es)	2009-07-16	2015-01-19	Novartis Ag	Inmunógenos desintoxicados de Escherichia coli
GB0918392D0 (en)	2009-10-20	2009-12-02	Novartis Ag	Diagnostic and therapeutic methods
GB0919690D0 (en)	2009-11-10	2009-12-23	Guy S And St Thomas S Nhs Foun	compositions for immunising against staphylococcus aureus
GB201009861D0 (en)	2010-06-11	2010-07-21	Novartis Ag	OMV vaccines
HUE033901T2 (en) *	2010-08-17	2018-01-29	3M Innovative Properties Co	Formulations and formulations for lipidized immune response modifying compounds and related processes
JP5978225B2 (ja)	2010-12-16	2016-08-24	大日本住友製薬株式会社	治療に有用なイミダゾ［４，５−ｃ］キノリン−１−イル誘導体
AU2012211278B2 (en)	2011-01-26	2016-11-10	Glaxosmithkline Biologicals Sa	RSV immunization regimen
LT2707385T (lt)	2011-05-13	2017-12-11	Glaxosmithkline Biologicals Sa	Iš anksto sulieti rsv f antigenai
US8728486B2 (en)	2011-05-18	2014-05-20	University Of Kansas	Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
JP6460789B2 (ja)	2011-06-03	2019-01-30	スリーエムイノベイティブプロパティズカンパニー	ポリエチレングリコールセグメントを有するヘテロ２官能性リンカー及び該リンカーから調製された免疫反応調節複合体
CA2838023C (en)	2011-06-03	2019-08-13	3M Innovative Properties Company	Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom
US20130023736A1 (en)	2011-07-21	2013-01-24	Stanley Dale Harpstead	Systems for drug delivery and monitoring
US9493517B2 (en)	2011-11-07	2016-11-15	Glaxosmithkline Biologicals Sa	Conjugates comprising an antigen and a carrier molecule
WO2013108272A2 (en)	2012-01-20	2013-07-25	International Centre For Genetic Engineering And Biotechnology	Blood stage malaria vaccine
CN112587671A (zh)	2012-07-18	2021-04-02	博笛生物科技有限公司	癌症的靶向免疫治疗
EP2941233B1 (de)	2013-01-07	2020-10-07	The Trustees of the University of Pennsylvania	Zusammensetzungen und verfahren zur behandlung von t-zelllymphom
EP3632458A1 (de)	2013-07-26	2020-04-08	INSERM (Institut National de la Santé et de la Recherche Médicale)	Verbindungen und pharmazeutische zusammensetzungen zur behandlung von bakterieninfektionen
AU2014347059B2 (en)	2013-11-05	2017-09-07	Solventum Intellectual Properties Company	Sesame oil based injection formulations
EP2870974A1 (de)	2013-11-08	2015-05-13	Novartis AG	Salmonella-Konjugatimpfstoffe
WO2015103989A1 (en)	2014-01-10	2015-07-16	Shanghai Birdie Biotech, Inc.	Compounds and compositions for immunotherapy
KR102297357B1 (ko)	2014-03-26	2021-09-02	글락소스미스클라인 바이오로지칼즈 에스.에이.	돌연변이 스태필로코쿠스 항원
CN112546231A (zh) *	2014-07-09	2021-03-26	博笛生物科技有限公司	用于治疗癌症的联合治疗组合物和联合治疗方法
DK3166976T3 (da)	2014-07-09	2022-04-11	Birdie Biopharmaceuticals Inc	Anti-pd-l1-kombinationer til behandling af tumorer
CN105461767B (zh) *	2014-08-07	2019-03-12	富力	一种连翘苷的化学合成方法
CN112587672A (zh)	2014-09-01	2021-04-02	博笛生物科技有限公司	用于治疗肿瘤的抗-pd-l1结合物
US10286065B2 (en)	2014-09-19	2019-05-14	Board Of Regents, The University Of Texas System	Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
JP6873980B2 (ja) *	2015-09-14	2021-05-19	ファイザー・インク	ＬＲＲＫ２阻害薬としての新規のイミダゾ［４，５−ｃ］キノリンおよびイミダゾ［４，５−ｃ］［１，５］ナフチリジン誘導体
WO2017058996A1 (en) *	2015-09-29	2017-04-06	The University Of Chicago	Polymer conjugate vaccines
US10526309B2 (en)	2015-10-02	2020-01-07	The University Of North Carolina At Chapel Hill	Pan-TAM inhibitors and Mer/Axl dual inhibitors
CN106943596A (zh)	2016-01-07	2017-07-14	博笛生物科技（北京）有限公司	用于治疗肿瘤的抗-cd20组合
CN115252792A (zh)	2016-01-07	2022-11-01	博笛生物科技有限公司	用于治疗肿瘤的抗-egfr组合
CN115350279A (zh)	2016-01-07	2022-11-18	博笛生物科技有限公司	用于治疗肿瘤的抗-her2组合
AU2017356673B2 (en)	2016-11-09	2023-11-09	Pulmotect, Inc.	Methods and compositions for adaptive immune modulation
CN108794467A (zh)	2017-04-27	2018-11-13	博笛生物科技有限公司	2-氨基-喹啉衍生物
CA3067268A1 (en)	2017-06-23	2018-12-27	Birdie Biopharmaceuticals, Inc.	Crystalline resiquimod monosulfate anhydrate and its preparation and uses
US11306083B2 (en)	2017-12-20	2022-04-19	3M Innovative Properties Company	Amide substituted imidazo[4,5-C]quinoline compounds with a branched chain linking group for use as an immune response modifier
JP2021512953A (ja)	2018-02-02	2021-05-20	メイベリックスオンコロジーインコーポレイテッド	ゲムシタビンモノホスフェートの小分子薬物コンジュゲート
EP3759107A1 (de) *	2018-02-28	2021-01-06	3M Innovative Properties Company	Substituierte imidazo[4,5-c]chinolin-verbindungen mit einer n-1-verzweigten gruppe
KR20200128116A (ko)	2018-02-28	2020-11-11	화이자 인코포레이티드	Il-15 변이체 및 이의 용도
CA3100829A1 (en)	2018-05-23	2019-11-28	Pfizer Inc.	Antibodies specific for gucy2c and uses thereof
EP3797121A1 (de)	2018-05-23	2021-03-31	Pfizer Inc	Cd3-spezifische antikörper und verwendungen davon
US11884662B2 (en)	2018-05-24	2024-01-30	3M Innovative Properties Company	N-1 branched cycloalkyl substituted imidazo[4,5-c]quinoline compounds, compositions, and methods
WO2020023680A1 (en) *	2018-07-24	2020-01-30	Torque Therapeutics, Inc.	Tlr7/8 agonists and liposome compositions
EP3887369A1 (de) *	2018-11-26	2021-10-06	3M Innovative Properties Company	N-1-verzweigte alkylethersubstituierte imidazo[4,5-c]chinolinverbindungen, zusammensetzungen und verfahren
US20220370606A1 (en)	2018-12-21	2022-11-24	Pfizer Inc.	Combination Treatments Of Cancer Comprising A TLR Agonist
WO2020163118A1 (en) *	2019-02-07	2020-08-13	Canwell Biotech Limited	Phosphorus imidazoquinoline amine derivatives, pharmaceutical compositions and therapeutic methods thereof
WO2020168017A1 (en)	2019-02-12	2020-08-20	Ambrx, Inc.	Compositions containing, methods and uses of antibody-tlr agonist conjugates
US20220411421A1 (en) *	2019-10-29	2022-12-29	Prime Reach Trading Limited	4-amino-imidazoquinoline compounds and use thereof
WO2021116420A1 (en)	2019-12-13	2021-06-17	INSERM (Institut National de la Santé et de la Recherche Médicale)	Use of tlr7 and/or tlr8 agonists for the treatment of leptospirosis
MX2022006578A (es)	2019-12-17	2022-07-04	Pfizer	Anticuerpos especificos para cd47, pd-l1 y sus usos.
JP2023533793A (ja)	2020-07-17	2023-08-04	ファイザー・インク	治療用抗体およびそれらの使用
EP4199968A1 (de)	2020-08-20	2023-06-28	Ambrx, Inc.	Antikörper-tlr-agonist-konjugate, verfahren und verwendungen davon

Family Cites Families (98)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2135210A (en) *	1937-03-13	1938-11-01	John R Farrar	Golf ball
US3314941A (en)	1964-06-23	1967-04-18	American Cyanamid Co	Novel substituted pyridodiazepins
US3692907A (en) *	1970-10-27	1972-09-19	Richardson Merrell Inc	Treating viral infections with bis-basic ethers and thioethers of fluorenone and fluorene and pharmaceutical compositons of the same
US3819190A (en) *	1972-10-02	1974-06-25	D Nepela	Golf ball
US4284276A (en) *	1980-02-13	1981-08-18	Worst Joseph C	Grooved golf ball
IL73534A (en)	1983-11-18	1990-12-23	Riker Laboratories Inc	1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
ZA848968B (en)	1983-11-18	1986-06-25	Riker Laboratories Inc	1h-imidazo(4,5-c)quinolines and 1h-imidazo(4,5-c)quinolin-4-amines
US4880779A (en) *	1987-07-31	1989-11-14	Research Corporation Technologies, Inc.	Method of prevention or treatment of AIDS by inhibition of human immunodeficiency virus
US5238944A (en)	1988-12-15	1993-08-24	Riker Laboratories, Inc.	Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
US5756747A (en)	1989-02-27	1998-05-26	Riker Laboratories, Inc.	1H-imidazo 4,5-c!quinolin-4-amines
US5037986A (en)	1989-03-23	1991-08-06	Minnesota Mining And Manufacturing Company	Olefinic 1H-imidazo[4,5-c]quinolin-4-amines
US4929624A (en)	1989-03-23	1990-05-29	Minnesota Mining And Manufacturing Company	Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
NZ232740A (en)	1989-04-20	1992-06-25	Riker Laboratories Inc	Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster
US4988815A (en) *	1989-10-26	1991-01-29	Riker Laboratories, Inc.	3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
US5054153A (en) *	1989-12-01	1991-10-08	Silliman Paul D	Golf club cleaner
DK0553202T3 (da) *	1990-10-05	1995-07-03	Minnesota Mining & Mfg	Fremgangsmåde til fremstilling af imidazo(4,5-c)quinolin-4-aminer
DE69229114T2 (de) *	1991-03-01	1999-11-04	Minnesota Mining & Mfg	1,2-substituierte 1h-imidazo[4,5-c]chinolin-4-amine
US5389640A (en)	1991-03-01	1995-02-14	Minnesota Mining And Manufacturing Company	1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5175296A (en) *	1991-03-01	1992-12-29	Minnesota Mining And Manufacturing Company	Imidazo[4,5-c]quinolin-4-amines and processes for their preparation
US5268376A (en)	1991-09-04	1993-12-07	Minnesota Mining And Manufacturing Company	1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5266575A (en) *	1991-11-06	1993-11-30	Minnesota Mining And Manufacturing Company	2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
IL105325A (en)	1992-04-16	1996-11-14	Minnesota Mining & Mfg	Immunogen/vaccine adjuvant composition
FR2692159B1 (fr) *	1992-06-10	1996-10-11	Vartan Berberian	Boule pour jeux de boules et procedes d'obtention d'une telle boule.
US5395937A (en) *	1993-01-29	1995-03-07	Minnesota Mining And Manufacturing Company	Process for preparing quinoline amines
CZ288182B6 (en)	1993-07-15	2001-05-16	Minnesota Mining & Mfg	Imidazo[4,5-c]pyridine-4-amines and pharmaceutical preparations based thereon
US5352784A (en) *	1993-07-15	1994-10-04	Minnesota Mining And Manufacturing Company	Fused cycloalkylimidazopyridines
US5648516A (en)	1994-07-20	1997-07-15	Minnesota Mining And Manufacturing Company	Fused cycloalkylimidazopyridines
US5644063A (en)	1994-09-08	1997-07-01	Minnesota Mining And Manufacturing Company	Imidazo[4,5-c]pyridin-4-amine intermediates
US5482936A (en)	1995-01-12	1996-01-09	Minnesota Mining And Manufacturing Company	Imidazo[4,5-C]quinoline amines
JPH09116911A (ja) *	1995-10-20	1997-05-02	Canon Inc	撮像システム
JPH09208584A (ja)	1996-01-29	1997-08-12	Terumo Corp	アミド誘導体、およびそれを含有する医薬製剤、および合成中間体
JPH09255926A (ja)	1996-03-26	1997-09-30	Diatex Co Ltd	粘着テープ
US5741908A (en) *	1996-06-21	1998-04-21	Minnesota Mining And Manufacturing Company	Process for reparing imidazoquinolinamines
US5693811A (en) *	1996-06-21	1997-12-02	Minnesota Mining And Manufacturing Company	Process for preparing tetrahdroimidazoquinolinamines
US5759109A (en) *	1996-09-09	1998-06-02	Martini; Byron Rocco	Simulated golf ball instructional device
CA2268957C (en)	1996-10-25	2008-04-29	Minnesota Mining And Manufacturing Company	Immune response modifier compounds for treatment of th2 mediated and related diseases
US5939090A (en)	1996-12-03	1999-08-17	3M Innovative Properties Company	Gel formulations for topical drug delivery
EP0894797A4 (de) *	1997-01-09	2001-08-16	Terumo Corp	Neue amidderivate und intermediate zu ihrer synthese
UA67760C2 (uk) *	1997-12-11	2004-07-15	Міннесота Майнінг Енд Мануфакчурінг Компані	Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
JPH11222432A (ja)	1998-02-03	1999-08-17	Terumo Corp	インターフェロンを誘起するアミド誘導体を含有する外用剤
JPH11255926A (ja)	1998-03-13	1999-09-21	Toray Ind Inc	シリコーン成型品およびその製造方法
US6239965B1 (en) *	1998-05-22	2001-05-29	Matsushita Electric Industrial Co., Ltd.	Electrolytic capacitor and method of producing the same
US6110929A (en)	1998-07-28	2000-08-29	3M Innovative Properties Company	Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
JP2000119271A (ja)	1998-08-12	2000-04-25	Hokuriku Seiyaku Co Ltd	１ｈ―イミダゾピリジン誘導体
US20020058674A1 (en)	1999-01-08	2002-05-16	Hedenstrom John C.	Systems and methods for treating a mucosal surface
CN1555264A (zh) *	1999-01-08	2004-12-15	3M	用于治疗粘膜病症的含咪喹莫特或其它免疫应答调节剂的制剂
US6558951B1 (en) *	1999-02-11	2003-05-06	3M Innovative Properties Company	Maturation of dendritic cells with immune response modifying compounds
JP2000247884A (ja)	1999-03-01	2000-09-12	Sumitomo Pharmaceut Co Ltd	アラキドン酸誘発皮膚疾患治療剤
US6573273B1 (en) *	1999-06-10	2003-06-03	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6541485B1 (en) *	1999-06-10	2003-04-01	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6756382B2 (en)	1999-06-10	2004-06-29	3M Innovative Properties Company	Amide substituted imidazoquinolines
US6451810B1 (en)	1999-06-10	2002-09-17	3M Innovative Properties Company	Amide substituted imidazoquinolines
US6331539B1 (en)	1999-06-10	2001-12-18	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
US6376669B1 (en) *	1999-11-05	2002-04-23	3M Innovative Properties Company	Dye labeled imidazoquinoline compounds
US6894060B2 (en)	2000-03-30	2005-05-17	3M Innovative Properties Company	Method for the treatment of dermal lesions caused by envenomation
US20020055517A1 (en) *	2000-09-15	2002-05-09	3M Innovative Properties Company	Methods for delaying recurrence of herpes virus symptoms
JP2002145777A (ja)	2000-11-06	2002-05-22	Sumitomo Pharmaceut Co Ltd	アラキドン酸誘発皮膚疾患治療剤
US6545017B1 (en) *	2000-12-08	2003-04-08	3M Innovative Properties Company	Urea substituted imidazopyridines
US6667312B2 (en) *	2000-12-08	2003-12-23	3M Innovative Properties Company	Thioether substituted imidazoquinolines
US6664264B2 (en) *	2000-12-08	2003-12-16	3M Innovative Properties Company	Thioether substituted imidazoquinolines
US6677347B2 (en) *	2000-12-08	2004-01-13	3M Innovative Properties Company	Sulfonamido ether substituted imidazoquinolines
EP1360486A2 (de)	2000-12-08	2003-11-12	3M Innovative Properties Company	Screeningverfahren zur identifizierung von selektiven interferon-alpha-induzierenden verbindungen
UA74593C2 (en)	2000-12-08	2006-01-16	3M Innovative Properties Co	Substituted imidazopyridines
US6664265B2 (en) *	2000-12-08	2003-12-16	3M Innovative Properties Company	Amido ether substituted imidazoquinolines
US6677348B2 (en)	2000-12-08	2004-01-13	3M Innovative Properties Company	Aryl ether substituted imidazoquinolines
UA75622C2 (en)	2000-12-08	2006-05-15	3M Innovative Properties Co	Aryl ether substituted imidazoquinolines, pharmaceutical composition based thereon
US6525064B1 (en) *	2000-12-08	2003-02-25	3M Innovative Properties Company	Sulfonamido substituted imidazopyridines
US6664260B2 (en)	2000-12-08	2003-12-16	3M Innovative Properties Company	Heterocyclic ether substituted imidazoquinolines
US6660747B2 (en) *	2000-12-08	2003-12-09	3M Innovative Properties Company	Amido ether substituted imidazoquinolines
US6660735B2 (en) *	2000-12-08	2003-12-09	3M Innovative Properties Company	Urea substituted imidazoquinoline ethers
US6545016B1 (en) *	2000-12-08	2003-04-08	3M Innovative Properties Company	Amide substituted imidazopyridines
JP2005519849A (ja)	2001-06-15	2005-07-07	スリーエムイノベイティブプロパティズカンパニー	歯周病の治療用免疫応答調節剤
US20030133913A1 (en)	2001-08-30	2003-07-17	3M Innovative Properties Company	Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
AU2002360278A1 (en)	2001-10-12	2003-11-11	Coley Pharmaceutical Gmbh	Methods and products for enhancing immune responses using imidazoquinoline compounds
DK1719511T3 (da)	2001-11-16	2009-04-14	Coley Pharm Group Inc	N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methansulfonamid, en farmaceutisk sammensætning omfattende samme, og anvendelse deraf
ES2312659T3 (es)	2001-11-29	2009-03-01	3M Innovative Properties Company	Formulaciones farmaceuticas que comprenden un modificador de la respuesta inmune.
US6677349B1 (en)	2001-12-21	2004-01-13	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
JP2005518433A (ja)	2002-02-22	2005-06-23	スリーエムイノベイティブプロパティズカンパニー	Ｕｖｂ−誘導免疫抑制を軽減し治療する方法
GB0211649D0 (en)	2002-05-21	2002-07-03	Novartis Ag	Organic compounds
AU2003233519A1 (en)	2002-05-29	2003-12-19	3M Innovative Properties Company	Process for imidazo(4,5-c)pyridin-4-amines
JP2005538057A (ja)	2002-06-07	2005-12-15	スリーエムイノベイティブプロパティズカンパニー	エーテル置換イミダゾピリジン
AU2003299863B2 (en)	2002-08-15	2009-09-24	3M Innovative Properties Company	Immunostimulatory compositions and methods of stimulating an immune response
AU2003299082A1 (en)	2002-09-26	2004-04-19	3M Innovative Properties Company	1h-imidazo dimers
AU2003287316A1 (en)	2002-12-11	2004-06-30	3M Innovative Properties Company	Assays relating to toll-like receptor activity
AU2003287324A1 (en)	2002-12-11	2004-06-30	3M Innovative Properties Company	Gene expression systems and recombinant cell lines
AU2003301052A1 (en) *	2002-12-20	2004-07-22	3M Innovative Properties Company	Aryl / hetaryl substituted imidazoquinolines
US7387271B2 (en)	2002-12-30	2008-06-17	3M Innovative Properties Company	Immunostimulatory combinations
WO2004071459A2 (en)	2003-02-13	2004-08-26	3M Innovative Properties Company	Methods and compositions related to irm compounds and toll-like receptor 8
US7485432B2 (en)	2003-02-27	2009-02-03	3M Innovative Properties Company	Selective modulation of TLR-mediated biological activity
AU2004218349A1 (en)	2003-03-04	2004-09-16	3M Innovative Properties Company	Prophylactic treatment of UV-induced epidermal neoplasia
CA2517655A1 (en)	2003-03-07	2004-09-23	3M Innovative Properties Company	1-amino 1h-imidazoquinolines
CA2518445A1 (en)	2003-03-13	2004-09-23	3M Innovative Properties Company	Method of tattoo removal
MXPA05009694A (es)	2003-03-13	2005-10-20	3M Innovative Properties Co	Metodos para mejorar la calidad de la piel.
WO2004080293A2 (en)	2003-03-13	2004-09-23	3M Innovative Properties Company	Methods for diagnosing skin lesions
US20040192585A1 (en)	2003-03-25	2004-09-30	3M Innovative Properties Company	Treatment for basal cell carcinoma
WO2004087049A2 (en)	2003-03-25	2004-10-14	3M Innovative Properties Company	Selective activation of cellular activities mediated through a common toll-like receptor
AU2004244962A1 (en)	2003-04-10	2004-12-16	3M Innovative Properties Company	Delivery of immune response modifier compounds using metal-containing particulate support materials
US7576068B2 (en)	2003-09-05	2009-08-18	Anadys Pharmaceuticals, Inc.	Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus

2001
- 2001-06-12 UA UA2003065277A patent/UA75622C2/uk unknown
- 2001-06-12 UA UA2003065275A patent/UA74852C2/uk unknown
- 2001-12-06 AT AT01987297T patent/ATE296301T1/de active
- 2001-12-06 DE DE60111076T patent/DE60111076T2/de not_active Expired - Lifetime
- 2001-12-06 RU RU2003116063/04A patent/RU2003116063A/ru not_active Application Discontinuation
- 2001-12-06 DK DK01992018T patent/DK1343784T3/da active
- 2001-12-06 IL IL15604401A patent/IL156044A0/xx unknown
- 2001-12-06 JP JP2002547930A patent/JP2004515501A/ja active Pending
- 2001-12-06 SI SI200130720T patent/SI1341790T1/sl unknown
- 2001-12-06 EP EP01987283A patent/EP1341790B1/de not_active Expired - Lifetime
- 2001-12-06 BR BR0116047-8A patent/BR0116047A/pt not_active IP Right Cessation
- 2001-12-06 NZ NZ526106A patent/NZ526106A/en not_active IP Right Cessation
- 2001-12-06 RU RU2003116649/04A patent/RU2351598C2/ru not_active IP Right Cessation
- 2001-12-06 KR KR10-2003-7007537A patent/KR20030070050A/ko not_active Application Discontinuation
- 2001-12-06 EP EP01990852A patent/EP1339715A2/de not_active Withdrawn
- 2001-12-06 US US10/013,202 patent/US6670372B2/en not_active Expired - Fee Related
- 2001-12-06 WO PCT/US2001/046359 patent/WO2002046188A2/en active IP Right Grant
- 2001-12-06 RU RU2003116060/04A patent/RU2302418C2/ru active
- 2001-12-06 AU AU2002230618A patent/AU2002230618B2/en not_active Ceased
- 2001-12-06 PL PL01365883A patent/PL365883A1/xx not_active Application Discontinuation
- 2001-12-06 US US10/013,060 patent/US6656938B2/en not_active Expired - Fee Related
- 2001-12-06 MX MXPA03004975A patent/MXPA03004975A/es active IP Right Grant
- 2001-12-06 EP EP01987297A patent/EP1341791B1/de not_active Expired - Lifetime
- 2001-12-06 PL PL366330A patent/PL207340B1/pl not_active IP Right Cessation
- 2001-12-06 CZ CZ20031561A patent/CZ20031561A3/cs unknown
- 2001-12-06 SK SK715-2003A patent/SK7152003A3/sk unknown
- 2001-12-06 JP JP2002547926A patent/JP2004523498A/ja active Pending
- 2001-12-06 IL IL15590301A patent/IL155903A0/xx unknown
- 2001-12-06 WO PCT/US2001/046704 patent/WO2002046193A2/en active IP Right Grant
- 2001-12-06 JP JP2002547925A patent/JP4437189B2/ja not_active Expired - Fee Related
- 2001-12-06 CN CNB018199070A patent/CN1252070C/zh not_active Expired - Fee Related
- 2001-12-06 IL IL15590401A patent/IL155904A0/xx unknown
- 2001-12-06 IL IL15588401A patent/IL155884A0/xx unknown
- 2001-12-06 PL PL01365995A patent/PL365995A1/xx unknown
- 2001-12-06 ES ES01987283T patent/ES2281456T3/es not_active Expired - Lifetime
- 2001-12-06 PL PL01361948A patent/PL361948A1/xx not_active Application Discontinuation
- 2001-12-06 NZ NZ526088A patent/NZ526088A/xx unknown
- 2001-12-06 BR BR0116026-5A patent/BR0116026A/pt not_active IP Right Cessation
- 2001-12-06 IL IL15595001A patent/IL155950A0/xx unknown
- 2001-12-06 RU RU2003116059/04A patent/RU2308456C2/ru not_active IP Right Cessation
- 2001-12-06 CA CA002431151A patent/CA2431151A1/en not_active Withdrawn
- 2001-12-06 BR BRPI0116464-3A patent/BR0116464A/pt not_active IP Right Cessation
- 2001-12-06 NZ NZ526089A patent/NZ526089A/en unknown
- 2001-12-06 CA CA002436983A patent/CA2436983A1/en not_active Abandoned
- 2001-12-06 EE EEP200300272A patent/EE200300272A/xx unknown
- 2001-12-06 CZ CZ20031562A patent/CZ20031562A3/cs unknown
- 2001-12-06 HU HU0400704A patent/HUP0400704A2/hu unknown
- 2001-12-06 CN CNA018201687A patent/CN1479739A/zh active Pending
- 2001-12-06 KR KR10-2003-7007539A patent/KR20040047733A/ko not_active Application Discontinuation
- 2001-12-06 HU HU0600605A patent/HUP0600605A2/hu unknown
- 2001-12-06 AU AU3951602A patent/AU3951602A/xx active Pending
- 2001-12-06 NZ NZ526087A patent/NZ526087A/en unknown
- 2001-12-06 ES ES01992018T patent/ES2260323T3/es not_active Expired - Lifetime
- 2001-12-06 KR KR10-2003-7007538A patent/KR20040028691A/ko not_active Application Discontinuation
- 2001-12-06 JP JP2002547928A patent/JP2004521092A/ja not_active Ceased
- 2001-12-06 PL PL01366115A patent/PL366115A1/xx not_active Application Discontinuation
- 2001-12-06 AU AU2002232482A patent/AU2002232482B2/en not_active Ceased
- 2001-12-06 SK SK710-2003A patent/SK287264B6/sk not_active IP Right Cessation
- 2001-12-06 CA CA2436980A patent/CA2436980C/en not_active Expired - Fee Related
- 2001-12-06 AU AU3953002A patent/AU3953002A/xx active Pending
- 2001-12-06 CA CA2436846A patent/CA2436846C/en not_active Expired - Fee Related
- 2001-12-06 NZ NZ526086A patent/NZ526086A/en unknown
- 2001-12-06 BR BR0116470-8A patent/BR0116470A/pt not_active IP Right Cessation
- 2001-12-06 CA CA002436984A patent/CA2436984A1/en not_active Abandoned
- 2001-12-06 SK SK711-2003A patent/SK7112003A3/sk unknown
- 2001-12-06 WO PCT/US2001/046696 patent/WO2002046191A2/en active IP Right Grant
- 2001-12-06 KR KR10-2003-7007532A patent/KR20040023576A/ko not_active Application Discontinuation
- 2001-12-06 AU AU2002232497A patent/AU2002232497B2/en not_active Ceased
- 2001-12-06 DE DE60117859T patent/DE60117859T2/de not_active Expired - Fee Related
- 2001-12-06 CA CA002430844A patent/CA2430844A1/en not_active Withdrawn
- 2001-12-06 DE DE60126645T patent/DE60126645T2/de not_active Expired - Fee Related
- 2001-12-06 ES ES01987297T patent/ES2242782T3/es not_active Expired - Lifetime
- 2001-12-06 PT PT01987283T patent/PT1341790E/pt unknown
- 2001-12-06 DK DK01987297T patent/DK1341791T3/da active
- 2001-12-06 EP EP01992005A patent/EP1341792A2/de not_active Withdrawn
- 2001-12-06 MX MXPA03004974A patent/MXPA03004974A/es active IP Right Grant
- 2001-12-06 RU RU2003116123/04A patent/RU2003116123A/ru not_active Application Discontinuation
- 2001-12-06 PT PT01987297T patent/PT1341791E/pt unknown
- 2001-12-06 CN CNB018201598A patent/CN1247575C/zh not_active Expired - Fee Related
- 2001-12-06 HU HU0600338A patent/HUP0600338A2/hu active IP Right Revival
- 2001-12-06 AU AU3951702A patent/AU3951702A/xx active Pending
- 2001-12-06 CZ CZ20031592A patent/CZ303462B6/cs not_active IP Right Cessation
- 2001-12-06 MX MXPA03005012A patent/MXPA03005012A/es active IP Right Grant
- 2001-12-06 HU HU0600600A patent/HUP0600600A2/hu unknown
- 2001-12-06 RU RU2003116061/04A patent/RU2315049C2/ru not_active IP Right Cessation
- 2001-12-06 JP JP2002547929A patent/JP2004515500A/ja not_active Withdrawn
- 2001-12-06 JP JP2002547927A patent/JP2004529078A/ja active Pending
- 2001-12-06 AT AT01987283T patent/ATE353895T1/de not_active IP Right Cessation
- 2001-12-06 WO PCT/US2001/046582 patent/WO2002046190A2/en active IP Right Grant
- 2001-12-06 KR KR10-2003-7007535A patent/KR20040028690A/ko not_active Application Discontinuation
- 2001-12-06 AU AU3248202A patent/AU3248202A/xx active Pending
- 2001-12-06 EP EP01987282A patent/EP1341789A2/de not_active Ceased
- 2001-12-06 PL PL01365907A patent/PL365907A1/xx not_active Application Discontinuation
- 2001-12-06 AT AT01992018T patent/ATE319711T1/de not_active IP Right Cessation
- 2001-12-06 EP EP01992018A patent/EP1343784B1/de not_active Expired - Lifetime
- 2001-12-06 NZ NZ526105A patent/NZ526105A/en unknown
- 2001-12-06 AU AU2002239530A patent/AU2002239530B2/en not_active Ceased
- 2001-12-06 EE EEP200300268A patent/EE200300268A/xx unknown
- 2001-12-06 HU HU0700062A patent/HUP0700062A2/hu active IP Right Revival
- 2001-12-06 CZ CZ20031591A patent/CZ20031591A3/cs unknown
- 2001-12-06 AU AU3249702A patent/AU3249702A/xx active Pending
- 2001-12-06 CZ CZ20031563A patent/CZ20031563A3/cs unknown
- 2001-12-06 DK DK01987283T patent/DK1341790T3/da active
- 2001-12-06 EE EEP200300271A patent/EE200300271A/xx unknown
- 2001-12-06 CZ CZ20031560A patent/CZ295848B6/cs not_active IP Right Cessation
- 2001-12-06 AU AU2002239517A patent/AU2002239517B2/en not_active Ceased
- 2001-12-06 SK SK684-2003A patent/SK6842003A3/sk not_active Application Discontinuation
- 2001-12-06 CN CNB018201679A patent/CN1297554C/zh not_active Expired - Fee Related
- 2001-12-06 MX MXPA03005011A patent/MXPA03005011A/es active IP Right Grant
- 2001-12-06 EE EEP200300270A patent/EE200300270A/xx unknown
- 2001-12-06 HU HU0400710A patent/HUP0400710A2/hu unknown
- 2001-12-06 EE EEP200300275A patent/EE200300275A/xx unknown
- 2001-12-06 KR KR10-2003-7007534A patent/KR20030070049A/ko active IP Right Grant
- 2001-12-06 SK SK713-2003A patent/SK287732B6/sk not_active IP Right Cessation
- 2001-12-06 CN CNA018201725A patent/CN1894244A/zh active Pending
- 2001-12-06 MX MXPA03004973A patent/MXPA03004973A/es not_active Application Discontinuation
- 2001-12-06 US US10/012,599 patent/US6683088B2/en not_active Expired - Fee Related
- 2001-12-06 WO PCT/US2001/046581 patent/WO2002046189A2/en active IP Right Grant
- 2001-12-06 BR BRPI0116032-0A patent/BR0116032A/pt not_active IP Right Cessation
- 2001-12-06 BR BRPI0116052-4A patent/BR0116052A/pt not_active Application Discontinuation
- 2001-12-06 AU AU3061802A patent/AU3061802A/xx active Pending
- 2001-12-06 AU AU2002239516A patent/AU2002239516B2/en not_active Ceased
- 2001-12-06 IL IL15604301A patent/IL156043A0/xx unknown
- 2001-12-06 MX MXPA03004972A patent/MXPA03004972A/es active IP Right Grant
- 2001-12-06 PL PL392462A patent/PL392462A1/pl unknown
- 2001-12-06 WO PCT/US2001/046697 patent/WO2002046192A2/en active IP Right Grant
- 2001-12-06 EE EEP200300274A patent/EE200300274A/xx unknown
- 2001-12-06 SK SK712-2003A patent/SK7122003A3/sk unknown
- 2001-12-06 CN CNB01820161XA patent/CN1253452C/zh not_active Expired - Fee Related
- 2001-12-07 TW TW090130404A patent/TWI293300B/zh active
- 2001-12-07 TW TW090130402A patent/TWI222972B/zh active
- 2001-12-07 TW TW090130401A patent/TW584633B/zh not_active IP Right Cessation
- 2001-12-10 AR ARP010105726A patent/AR035664A1/es active IP Right Grant
- 2001-12-10 AR ARP010105730A patent/AR035668A1/es unknown
- 2001-12-10 AR ARP010105729A patent/AR035667A1/es unknown
- 2001-12-10 AR ARP010105731A patent/AR035669A1/es unknown
- 2001-12-10 AR ARP010105728A patent/AR035666A1/es unknown
- 2001-12-10 AR ARP010105727A patent/AR035665A1/es unknown
2003
- 2003-05-28 NO NO20032449A patent/NO20032449D0/no not_active Application Discontinuation
- 2003-05-28 NO NO20032452A patent/NO20032452L/no not_active Application Discontinuation
- 2003-05-28 NO NO20032451A patent/NO20032451L/no not_active Application Discontinuation
- 2003-05-30 NO NO20032473A patent/NO326159B1/no not_active IP Right Cessation
- 2003-06-06 HR HR20030462A patent/HRP20030462A2/xx not_active Application Discontinuation
- 2003-06-06 NO NO20032596A patent/NO20032596D0/no not_active Application Discontinuation
- 2003-06-06 NO NO20032595A patent/NO20032595D0/no not_active Application Discontinuation
- 2003-06-06 HR HR20030461A patent/HRP20030461A2/hr not_active Application Discontinuation
- 2003-06-06 HR HR20030467A patent/HRP20030467B1/xx not_active IP Right Cessation
- 2003-06-06 HR HR20030466A patent/HRP20030466A2/hr not_active Application Discontinuation
- 2003-06-06 HR HR20030464A patent/HRP20030464A2/hr not_active Application Discontinuation
- 2003-06-06 HR HR20030463A patent/HRP20030463A2/xx not_active Application Discontinuation
- 2003-07-08 ZA ZA200305273A patent/ZA200305273B/en unknown
- 2003-07-08 ZA ZA200305274A patent/ZA200305274B/en unknown
- 2003-07-08 ZA ZA200305275A patent/ZA200305275B/en unknown
- 2003-07-08 ZA ZA200305270A patent/ZA200305270B/en unknown
- 2003-07-08 ZA ZA200305271A patent/ZA200305271B/en unknown
- 2003-07-08 ZA ZA2003/05272A patent/ZA200305272B/en unknown
- 2003-10-07 US US10/680,989 patent/US7049439B2/en not_active Expired - Fee Related
- 2003-10-29 US US10/696,753 patent/US6953804B2/en not_active Expired - Fee Related
- 2003-10-29 US US10/696,476 patent/US20040092545A1/en not_active Abandoned
2004
- 2004-09-20 HK HK04107230A patent/HK1064383A1/xx not_active IP Right Cessation
- 2004-11-11 HK HK04108904A patent/HK1066005A1/xx not_active IP Right Cessation
2005
- 2005-01-25 HK HK05100647A patent/HK1069166A1/xx not_active IP Right Cessation
- 2005-02-28 US US11/069,033 patent/US7132429B2/en not_active Expired - Fee Related
- 2005-05-19 US US11/132,900 patent/US7612083B2/en not_active Expired - Fee Related
- 2005-08-24 CY CY20051101024T patent/CY1105586T1/el unknown
2007
- 2007-05-09 CY CY20071100621T patent/CY1106569T1/el unknown
2009
- 2009-11-06 JP JP2009255040A patent/JP2010031040A/ja not_active Ceased

Also Published As

Publication number	Publication date
NZ526087A (en)	2004-11-26
HRP20030462A2 (en)	2004-04-30
JP2004529078A (ja)	2004-09-24
US6683088B2 (en)	2004-01-27
WO2002046191A2 (en)	2002-06-13
PT1341791E (pt)	2005-09-30
CZ20031560A3 (en)	2004-05-12
JP2004532810A (ja)	2004-10-28
HUP0600600A2 (en)	2006-11-28
ZA200305272B (en)	2005-01-26
NO20032473L (no)	2003-05-30
CZ20031563A3 (cs)	2004-02-18
CN1253452C (zh)	2006-04-26
ZA200305274B (en)	2004-10-18
US7612083B2 (en)	2009-11-03
CA2436980C (en)	2011-03-29
CZ20031591A3 (cs)	2003-11-12
RU2003116059A (ru)	2005-02-10
MXPA03004975A (es)	2003-09-05
ZA200305275B (en)	2004-10-08
CA2436984A1 (en)	2002-06-13
US20020193396A1 (en)	2002-12-19
ATE319711T1 (de)	2006-03-15
AU3951702A (en)	2002-06-18
BR0116047A (pt)	2003-09-30
MXPA03004973A (es)	2004-01-29
KR20040023576A (ko)	2004-03-18
SK6842003A3 (en)	2003-12-02
NO326159B1 (no)	2008-10-13
UA74852C2 (en)	2006-02-15
RU2003116123A (ru)	2004-11-20
PL365883A1 (en)	2005-01-10
DE60111076D1 (en)	2005-06-30
EP1341792A2 (de)	2003-09-10
EP1341790B1 (de)	2007-02-14
NO20032473D0 (no)	2003-05-30
CN1297554C (zh)	2007-01-31
CN1479738A (zh)	2004-03-03
US20040077678A1 (en)	2004-04-22
US6656938B2 (en)	2003-12-02
IL155884A0 (en)	2003-12-23
RU2302418C2 (ru)	2007-07-10
NO20032596L (no)	2003-06-06
CA2436983A1 (en)	2002-06-13
CN1479739A (zh)	2004-03-03
HUP0600605A2 (en)	2006-11-28
AU3953002A (en)	2002-06-18
CZ20031592A3 (cs)	2004-01-14
ES2242782T3 (es)	2005-11-16
HRP20030467A2 (en)	2004-04-30
ZA200305273B (en)	2004-10-08
DE60117859T2 (de)	2006-11-23
EP1341791A2 (de)	2003-09-10
CN1247575C (zh)	2006-03-29
CZ303462B6 (cs)	2012-09-26
NZ526088A (en)	2004-12-24
PL365907A1 (en)	2005-01-10
US20050148619A1 (en)	2005-07-07
CY1106569T1 (el)	2012-01-25
HRP20030463A2 (en)	2004-04-30
DE60111076T2 (de)	2006-05-04
KR20040047733A (ko)	2004-06-05
WO2002046190A2 (en)	2002-06-13
AR035664A1 (es)	2004-06-23
US20030158192A1 (en)	2003-08-21
US7132429B2 (en)	2006-11-07
CY1105586T1 (el)	2010-07-28
CN1511155A (zh)	2004-07-07
EE200300271A (et)	2003-10-15
EP1341789A2 (de)	2003-09-10
SI1341790T1 (sl)	2007-06-30
SK287264B6 (sk)	2010-04-07
JP2010031040A (ja)	2010-02-12
WO2002046190A3 (en)	2003-07-17
CA2431151A1 (en)	2002-06-13
NZ526106A (en)	2004-11-26
US7049439B2 (en)	2006-05-23
MXPA03004974A (es)	2003-09-05
JP2004521092A (ja)	2004-07-15
CZ20031562A3 (en)	2004-03-17
BR0116470A (pt)	2005-08-16
AU2002239530B2 (en)	2006-09-28
PL365995A1 (en)	2005-01-24
US6670372B2 (en)	2003-12-30
DE60117859D1 (de)	2006-05-04
EP1339715A2 (de)	2003-09-03
IL155904A0 (en)	2003-12-23
UA75622C2 (en)	2006-05-15
HK1069166A1 (en)	2005-05-13
IL156043A0 (en)	2003-12-23
HUP0600338A2 (en)	2006-08-28
HRP20030467B1 (en)	2009-04-30
SK7102003A3 (en)	2003-10-07
CN1537111A (zh)	2004-10-13
IL156044A0 (en)	2003-12-23
BR0116464A (pt)	2006-02-21
HK1064383A1 (en)	2005-01-28
KR20030070050A (ko)	2003-08-27
AR035665A1 (es)	2004-06-23
NO20032452L (no)	2003-07-16
US20050234088A1 (en)	2005-10-20
SK287732B6 (en)	2011-07-06
HUP0400710A2 (hu)	2004-06-28
EP1341791B1 (de)	2005-05-25
WO2002046192A2 (en)	2002-06-13
CZ20031561A3 (cs)	2004-04-14
SK7132003A3 (en)	2003-10-07
TWI222972B (en)	2004-11-01
RU2315049C2 (ru)	2008-01-20
DE60126645T2 (de)	2007-11-22
ZA200305270B (en)	2004-08-26
SK7122003A3 (en)	2003-11-04
AR035667A1 (es)	2004-06-23
EP1343784B1 (de)	2006-03-08
ATE296301T1 (de)	2005-06-15
NO20032596D0 (no)	2003-06-06
RU2003116063A (ru)	2004-12-10
AU2002232482B2 (en)	2006-10-19
CA2436980A1 (en)	2002-06-13
BR0116026A (pt)	2004-12-21
AU3951602A (en)	2002-06-18
NO20032452D0 (no)	2003-05-28
AU2002239516B2 (en)	2006-11-09
NZ526086A (en)	2005-11-25
HK1066005A1 (en)	2005-03-11
RU2308456C2 (ru)	2007-10-20
US6953804B2 (en)	2005-10-11
US20030212091A1 (en)	2003-11-13
AU3249702A (en)	2002-06-18
KR20030070049A (ko)	2003-08-27
HRP20030466A2 (en)	2004-06-30
EP1341790A2 (de)	2003-09-10
PL207340B1 (pl)	2010-12-31
EE200300274A (et)	2003-10-15
ES2260323T3 (es)	2006-11-01
IL155903A0 (en)	2003-12-23
ATE353895T1 (de)	2007-03-15
AU2002230618B2 (en)	2006-11-02
WO2002046192A3 (en)	2003-02-13
WO2002046193A2 (en)	2002-06-13
CN1894244A (zh)	2007-01-10
DK1341791T3 (da)	2005-09-19
WO2002046191A3 (en)	2003-03-13
PL361948A1 (en)	2004-10-18
SK7152003A3 (en)	2003-09-11
TW584633B (en)	2004-04-21
JP2004523498A (ja)	2004-08-05
WO2002046189A3 (en)	2003-03-20
EE200300270A (et)	2003-10-15
MXPA03004972A (es)	2004-01-29
EP1343784A2 (de)	2003-09-17
AU2002232497B2 (en)	2006-11-02
PL392462A1 (pl)	2010-11-22
HRP20030461A2 (en)	2004-06-30
NO20032595L (no)	2003-06-06
DK1341790T3 (da)	2007-06-04
EE200300272A (et)	2003-10-15
RU2003116649A (ru)	2005-02-10
HUP0400704A2 (hu)	2004-06-28
JP2004515500A (ja)	2004-05-27
AU2002239517B2 (en)	2006-11-02
NO20032449L (no)	2003-05-28
NO20032451D0 (no)	2003-05-28
AR035669A1 (es)	2004-06-23
WO2002046188A3 (en)	2003-03-13
WO2002046188A2 (en)	2002-06-13
KR20040028691A (ko)	2004-04-03
AU3061802A (en)	2002-06-18
BR0116032A (pt)	2006-02-21
CN1252070C (zh)	2006-04-19
NZ526105A (en)	2004-11-26
HUP0700062A2 (en)	2007-05-02
AU3248202A (en)	2002-06-18
AR035668A1 (es)	2004-06-23
CN1487939A (zh)	2004-04-07
CZ295848B6 (cs)	2005-11-16
NO20032449D0 (no)	2003-05-28
KR20040028690A (ko)	2004-04-03
RU2351598C2 (ru)	2009-04-10
PL366330A1 (en)	2005-01-24
TWI293300B (en)	2008-02-11
EE200300268A (et)	2003-10-15
HRP20030464A2 (en)	2004-06-30
WO2002046189A2 (en)	2002-06-13
EE200300275A (et)	2003-10-15
NO20032595D0 (no)	2003-06-06
PT1341790E (pt)	2007-05-31
ZA200305271B (en)	2004-10-08
CA2436846C (en)	2010-11-16
CA2430844A1 (en)	2002-06-13
NZ526089A (en)	2004-11-26
AR035666A1 (es)	2004-06-23
JP4437189B2 (ja)	2010-03-24
JP2004515501A (ja)	2004-05-27
US20040092545A1 (en)	2004-05-13
BR0116052A (pt)	2006-02-21
ES2281456T3 (es)	2007-10-01
SK7112003A3 (en)	2003-12-02
PL366115A1 (en)	2005-01-24
US20040106640A1 (en)	2004-06-03
IL155950A0 (en)	2003-12-23
DK1343784T3 (da)	2006-07-10
NO20032451L (no)	2003-07-16
MXPA03005012A (es)	2003-09-05
MXPA03005011A (es)	2003-09-05
WO2002046193A3 (en)	2003-02-27
CA2436846A1 (en)	2002-06-13

Legal Events

Date	Code	Title	Description
2008-03-13	8364	No opposition during term of opposition
2010-10-21	8339	Ceased/non-payment of the annual fee

Publication	Publication Date	Title
DE60126645D1 (de)	2007-03-29	Sulfonamidether - substituierte imidazochinoline
DE60140330D1 (de)	2009-12-10	Mikrokontaktprüfnadel
ATE290000T1 (de)	2005-03-15	Muscarinagonisten
ATE252099T1 (de)	2003-11-15	Biarylcarboxamide
DE10136334B8 (de)	2009-11-26	Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
ATE312098T1 (de)	2005-12-15	Thiazinoxazolidinon
DE50102988D1 (de)	2004-09-02	Bodenwischer
DE50104056D1 (de)	2004-11-18	Gewichtsmanschette
DE50100710D1 (de)	2003-11-06	Wischblatt
ATE298751T1 (de)	2005-07-15	7-oxopyridoryrimidine
ATE262530T1 (de)	2004-04-15	Indolochinazolinone
DE1274523T1 (de)	2003-05-28	Hochdruckumformspülanlage
DE50104651D1 (de)	2005-01-05	Fahrzeugfaltverdeck
DE10192638T1 (de)	2002-10-31	Bohrstangenladevorrichtung
ATE509008T1 (de)	2011-05-15	Sulfonylguanidine
DE10196064T1 (de)	2003-03-13	Halbleiterfotodektionsgerät
DE50100817D1 (de)	2003-11-27	Kugelgelenk
DE50011511D1 (de)	2005-12-08	Blowby-Heizung
AR028061A1 (es)	2003-04-23	2-enamino-cetonitrilos fenil-substituidos
AR027931A1 (es)	2003-04-16	Antitranspirantes
DE50007634D1 (de)	2004-10-07	Kardioplegieballonkatheter
DE10052925B4 (de)	2005-03-10	Schaukelbett
DE10085445T1 (de)	2003-02-27	Drahterodierbearbeitungseinrichtung
DE10195909T1 (de)	2003-02-20	Viehfüttervorrichtung
DE10195992T1 (de)	2003-02-27	Oberflächenendbearbeitungsbelag